C07K 16/112
Retroviridae
Official title: Retroviridae (F), e.g. leukemia viruses
C07K16/112 (Retroviridae) appears on 923 US grants and 1,174 published applications in this corpus.
Search patents in C07K- Granted patents
- 923
- Published applications
- 1,174
- Assignees
- 589
- Inventors
- 2,092
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 2 | 0 |
| 1985 | 1 | 0 |
| 1986 | 1 | 0 |
| 1987 | 2 | 0 |
| 1988 | 5 | 0 |
| 1989 | 7 | 0 |
| 1990 | 5 | 0 |
| 1991 | 4 | 0 |
| 1992 | 7 | 0 |
| 1993 | 12 | 0 |
| 1994 | 8 | 0 |
| 1995 | 8 | 0 |
| 1996 | 16 | 0 |
| 1997 | 34 | 0 |
| 1998 | 37 | 0 |
| 1999 | 33 | 0 |
| 2000 | 32 | 0 |
| 2001 | 33 | 5 |
| 2002 | 26 | 20 |
| 2003 | 20 | 35 |
| 2004 | 10 | 37 |
| 2005 | 12 | 29 |
| 2006 | 16 | 33 |
| 2007 | 12 | 29 |
| 2008 | 12 | 31 |
| 2009 | 21 | 32 |
| 2010 | 18 | 46 |
| 2011 | 10 | 44 |
| 2012 | 30 | 47 |
| 2013 | 20 | 41 |
| 2014 | 32 | 50 |
| 2015 | 23 | 54 |
| 2016 | 30 | 53 |
| 2017 | 28 | 48 |
| 2018 | 48 | 60 |
| 2019 | 46 | 60 |
| 2020 | 38 | 67 |
| 2021 | 57 | 62 |
| 2022 | 26 | 62 |
| 2023 | 34 | 60 |
| 2024 | 47 | 79 |
| 2025 | 34 | 55 |
| 2026 | 25 | 35 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Cell-receptor targeted exosomes6 Oct 2026US 12,751,930 B2City of Hope
- Immunostimulatory adjuvants6 Oct 2026US 12,752,000 B2Orionis Biosciences BV
- Anti-human immunodeficiency virus-1 antibodies and methods for uses thereof29 Sep 2026US 12,747,285 B2Grifols Diagnostic Solutions Inc.
- RNA encoding an antibody29 Sep 2026US 12,747,451 B2Cure Vac SE
- Rapid elicitation of broadly neutralizing bovine antibodies to HIV Env25 Aug 2026US 12,715,907 B2International AIDS Vaccine Initiative
- Tcr-mimic bispecific antibodies for hiv-11 Oct 2026US 2026/0297193 A1The Johns Hopkins University
- Novel methods of generating antibodies24 Sep 2026US 2026/0285952 A1Rutgers, The State University of New Jersey
- Therapeutic compounds and methods17 Sep 2026US 2026/0274914 A1Regents of the University of Minnesota
- Genetic engneering of b cell receptors and uses thereof in antigen-induced antibody secretion17 Sep 2026US 2026/0274916 A1Ramot at Tel-Aviv University Ltd.
- Antigen binding polypeptides, antigen binding polypeptide complexes and methods of use thereof17 Sep 2026US 2026/0274995 A1ModeX Therapeutics, Inc.
Most cited
By later US patents
- Anti-PD-L1 antibodies, compositions and articles of manufacture459US 8,217,149 B2Genentech, Inc. · 2012
- Metal chelate conjugated monoclonal antibodies310US 4,472,509 A1984
- Cells producing antibody compositions with increased antibody dependent cytotoxic activity247US 6,946,292 B2Kyowa Hakko Kogyo Co., Ltd. · 2005
- Chimeric receptor genes and cells transformed therewith196US 8,211,422 B2The United States of America, as represented by the Secretary, Department of Health and Human Services · 2012
- Multispecific chimeric receptors174US 6,103,521 ACell Genesys, Inc. · 2000